Key Points
- David K. Morris sold 187,855 shares on March 20 at an average price of $29.68 for proceeds of about $5.58 million, cutting his stake by 42.47% to 254,472 shares.
- That sale is part of a wave of large insider disposals — including directors who sold multi‑million share blocks and major shareholder Equity Fund L.P. Cardinal trimming its stake by ~44% — signaling significant insider liquidity events at the company.
- Despite the insider selling, Guardian posted a quarterly beat (EPS $0.37 vs. $0.27 estimate; revenue up 17.4%) and analysts remain generally bullish with a consensus target around $38 and multiple buy/strong‑buy ratings.
Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) insider David Morris sold 187,855 shares of the firm's stock in a transaction dated Friday, March 20th. The shares were sold at an average price of $29.68, for a total value of $5,575,536.40. Following the transaction, the insider owned 254,472 shares of the company's stock, valued at approximately $7,552,728.96. The trade was a 42.47% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Guardian Pharmacy Services Trading Down 2.8%
Shares of GRDN stock opened at $36.52 on Thursday. The stock has a market capitalization of $2.31 billion, a price-to-earnings ratio of 47.43 and a beta of 0.86. Guardian Pharmacy Services, Inc. has a 12-month low of $19.17 and a 12-month high of $38.12. The stock's 50-day moving average price is $32.62 and its 200-day moving average price is $29.87.
Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last announced its quarterly earnings results on Wednesday, March 11th. The company reported $0.37 EPS for the quarter, beating analysts' consensus estimates of $0.27 by $0.10. The company had revenue of $397.62 million during the quarter, compared to analyst estimates of $390.04 million. Guardian Pharmacy Services had a return on equity of 31.64% and a net margin of 3.40%.Guardian Pharmacy Services's revenue was up 17.4% on a year-over-year basis. As a group, research analysts predict that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current fiscal year.
Trending Headlines about Guardian Pharmacy Services
Here are the key news stories impacting Guardian Pharmacy Services this week:
- Neutral Sentiment: Market writeup noting broad insider activity at Guardian Pharmacy Services; useful context but not new filings. TipRanks article
- Negative Sentiment: Director Thomas J. Salentine, Jr. sold 3,570,677 shares at an average $29.68 (≈$106.0M). Filing: SEC filing
- Negative Sentiment: Director William E. Bindley sold 3,570,677 shares at $29.68 (≈$106.0M). Filing: SEC filing
- Negative Sentiment: Director John Ackerman sold 1,103,364 shares at $29.68 (≈$32.7M). Filing: SEC filing
- Negative Sentiment: Director/officer Fred Burke sold 671,432 shares at $29.68 (≈$19.9M). Filing: SEC filing
- Negative Sentiment: Insider Kendall Forbes sold 346,672 shares at $29.68 (≈$10.3M). Filing: SEC filing
- Negative Sentiment: Insider David K. Morris sold 187,855 shares at $29.68 (≈$5.6M). Filing: SEC filing
- Negative Sentiment: Major shareholder Equity Fund L.P. Cardinal sold 275,728 shares at $29.68 (≈$8.2M), a ~44% reduction in its stake. Filing: SEC filing
Hedge Funds Weigh In On Guardian Pharmacy Services
A number of institutional investors and hedge funds have recently modified their holdings of the stock. Brown Advisory Inc. raised its holdings in Guardian Pharmacy Services by 5.0% during the 2nd quarter. Brown Advisory Inc. now owns 1,682,476 shares of the company's stock valued at $35,854,000 after buying an additional 79,652 shares during the period. Valiant Capital Management L.P. lifted its position in Guardian Pharmacy Services by 15.8% in the fourth quarter. Valiant Capital Management L.P. now owns 1,232,463 shares of the company's stock worth $37,085,000 after buying an additional 167,741 shares during the last quarter. Wellington Management Group LLP boosted its stake in Guardian Pharmacy Services by 3.3% during the third quarter. Wellington Management Group LLP now owns 1,143,729 shares of the company's stock worth $30,000,000 after buying an additional 36,072 shares during the period. Franklin Resources Inc. boosted its stake in Guardian Pharmacy Services by 8.2% during the third quarter. Franklin Resources Inc. now owns 1,056,240 shares of the company's stock worth $27,705,000 after buying an additional 80,033 shares during the period. Finally, Vanguard Group Inc. increased its position in Guardian Pharmacy Services by 9.1% during the third quarter. Vanguard Group Inc. now owns 1,055,102 shares of the company's stock valued at $27,675,000 after acquiring an additional 88,296 shares during the last quarter.
Analyst Upgrades and Downgrades
A number of research analysts recently weighed in on the stock. Truist Financial raised their target price on shares of Guardian Pharmacy Services from $34.00 to $38.00 and gave the company a "buy" rating in a report on Thursday, March 12th. Raymond James Financial reaffirmed an "outperform" rating and set a $40.00 price target on shares of Guardian Pharmacy Services in a research note on Thursday, March 12th. Stephens increased their price objective on shares of Guardian Pharmacy Services from $35.00 to $36.00 and gave the company an "overweight" rating in a research report on Wednesday, January 14th. Zacks Research raised shares of Guardian Pharmacy Services from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, March 18th. Finally, Oppenheimer boosted their target price on shares of Guardian Pharmacy Services from $35.00 to $38.00 and gave the stock an "outperform" rating in a report on Thursday, March 12th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the stock has an average rating of "Buy" and a consensus target price of $38.00.
Check Out Our Latest Report on GRDN
About Guardian Pharmacy Services
(
Get Free Report)
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
